| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000031847 |
| Receipt No. | R000036297 |
| Scientific Title | Efficacy of prophylactic clipping for post-polypectomy delayed bleeding. |
| Date of disclosure of the study information | 2018/04/01 |
| Last modified on | 2022/09/07 (Ver. 3) |
| Basic information | ||
| Public title | Efficacy of prophylactic clipping for post-polypectomy delayed bleeding. | |
| Acronym | Efficacy of prophylactic clipping. | |
| Scientific Title | Efficacy of prophylactic clipping for post-polypectomy delayed bleeding. | |
| Scientific Title:Acronym | Efficacy of prophylactic clipping. | |
| Region |
|
|
| Condition | ||
| Condition | Colon polyps | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We prospectively investigate whether prophylactic clipping is effective in preventing bleeding after endoscopic colon polypectomy. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Incidence of post-polypectomy bleeding |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | clipping group | |
| Interventions/Control_2 | non-clipping group | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Those receiving endoscopic colon polypectomy at digestive endoscopy unit of Shiga University of Medical Science Hospital.
(2) Persons whose age is 20 years or older (3) Those who can consent to participate in research by their own will |
|||
| Key exclusion criteria | (1) Polyp more than 20 mm in diameter
(2) Pedunculated polyp more than 10 mm in diameter (3) When bleeding or exposed blood vessels are seen immediately after polypectomy (4) Persons with liver cirrhosis, blood disorders, dialysis patients, etc. and have blood platelet counts of 50,000 or less or PT-INR of 2.6 or more (5) Those who are taking oral antithrombotic drugs and who are judged to be inappropriate for endoscopic polypectomy in accordance with the latest "endoscopic clinical practice guideline for antithrombotic drug recipients" (6) Those who are taking oral antithrombotic drugs and who are in need of substitution of heparin for antithrombotic drugs in accordance with the latest "endoscopic clinical practice guideline for antithrombotic drug recipients" (7) Person who is scheduled for MRI examination (8) Those who refuse research cooperation (9) Others who judged inappropriate by a doctor |
|||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shiga University of Medical Science | ||||||
| Division name | Division of gastroenterology | ||||||
| Zip code | |||||||
| Address | Seta Tsukinowa-cho, Otsu, Shiga, JAPAN | ||||||
| TEL | 077-548-2217 | ||||||
| dr13037@belle.shiga-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Shiga University of Medical Science | ||||||
| Division name | Division of gastroenterology | ||||||
| Zip code | |||||||
| Address | Seta Tsukinowa-cho, Otsu, Shiga, JAPAN | ||||||
| TEL | 077-548-2217 | ||||||
| Homepage URL | |||||||
| dr13037@belle.shiga-med.ac.jp | |||||||
| Sponsor | |
| Institute | Shiga University of Medical Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shiga University of Medical Science |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036297 |